About this trial
The ambition of the project is to help with the primal colonisation of babies born by caesarean section and to improve the lipid composition of an infant formula, in order to reduce the short- and long-term health problems associated with caesarean births. This population, which represents around 20% of babies born in France, has not yet received any specific care to date.
The study aims to develop an optimized infant formula. It includes: (1) isolation of probiotics from breast milk from nursing mothers and stool samples from their babies born vaginally, (2) formulation of an improved milk enriched with physiological lipids and selected probiotics, and (3) preclinical evaluation of its beneficial effects in a cesarean birth model.
Eligibility criteria
Qualifiers
None
Disqualifiers
Under the age of 18
Breastfeeding for 6 months or more
Having been on antibiotic therapy in the 6 months prior to sampling
Having taken probiotics in the 6 months prior to sampling
Trial design
Treatments tested in this trial
- Not listed